Caris Life Sciences (CAI) FCF Margin (2024 - 2026)

Caris Life Sciences' FCF Margin history runs 3 years deep, the most recent figure standing at 10.42% for Q1 2026.

• In Q1 2026, FCF Margin rose 3857.0% year-over-year to 10.42%; the TTM figure through Mar 2026 stood at 13.61% (up 4457.0% YoY), while the FY2025 annual figure was 8.24%, up 6821.0% from the prior year.
• FCF Margin was 10.42% for Q1 2026 at Caris Life Sciences, down from 13.55% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 25.52% in Q3 2025 to a low of 70.12% in Q3 2024.
• Historically, FCF Margin has averaged 10.33% across 3 years, with a median of 3.25% in 2025.
• The sharpest annual moves came in 2025 and 2026: FCF Margin soared 9564 bps in 2025, then soared 3857 bps in 2026.
• A 3-year view of FCF Margin shows it stood at 26.8% in 2024, then soared by 151 bps to 13.55% in 2025, then decreased by 23 bps to 10.42% in 2026.
• The last three FCF Margin figures came in at 10.42% (Q1 2026), 13.55% (Q4 2025), and 25.52% (Q3 2025), per Business Quant data.